BlackRock Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

BlackRock Group’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.22M	Buy	66,021 +28,060	+74%	+$546K	﹤0.01%	2035
2016 Q3	$721K	Buy	37,961 +26,516	+232%	+$481K	﹤0.01%	2177
2016 Q2	$184K	Sell	11,445 -184	-2%	-$2.6K	﹤0.01%	2606
2016 Q1	$140K	Buy	11,629 +4,439	+62%	+$52.3K	﹤0.01%	2667
2015 Q4	$102K	Sell	7,190 -245	-3%	-$3.24K	﹤0.01%	2677
2015 Q3	$87K	Buy	7,435 +1,759	+31%	+$26.4K	﹤0.01%	2737
2015 Q2	$100K	Buy	+5,676	New	+$88.5K	﹤0.01%	2746
2014 Q4	–	Sell	-8,001	Closed	-$93K	–	2872
2014 Q3	$93K	Buy	+8,001	New	+$83.3K	﹤0.01%	2600

Other funds holding AMPH

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock Group's AMPH Position: Q4 2016 in Review

BlackRock Group increased its Amphastar Pharmaceuticals (AMPH) stake by 74% in Q4 2016, buying an estimated $546K and bringing the position to 66,021 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2035.

BlackRock Group first reported a position in AMPH in Q3 2014 and has held it in 8 quarters since. 138 funds tracked by Wall St. Rank hold AMPH as of Q4 2016.

BlackRock Group held 66,021 shares of Amphastar Pharmaceuticals worth $1.22M as of Q4 2016.
BlackRock Group bought 28,060 Amphastar Pharmaceuticals shares in Q4 2016, an estimated $546K.
Amphastar Pharmaceuticals made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2035 holding.
BlackRock Group first reported a position in Amphastar Pharmaceuticals in Q3 2014 and has held it in 8 quarters since.
138 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.